Rocket Pharmaceuticals Inc
NASDAQ:RCKT

Watchlist Manager
Rocket Pharmaceuticals Inc Logo
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Watchlist
Price: 3.43 USD 0.59% Market Closed
Market Cap: 371.2m USD

Relative Value

There is not enough data to reliably calculate the relative value of RCKT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RCKT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-6.8
Industry
23.7
Forward
-1.6
vs History
vs Industry
Median 3Y
-7.7
Median 5Y
-8.4
Industry
22
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-8
Industry
23.8
vs History
88
vs Industry
41
Median 3Y
3.4
Median 5Y
3.4
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
-5
Median 5Y
-5.2
Industry
6.4
Forward
-0.8
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-5.1
Industry
7
Forward
-0.7
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-6.5
Industry
8.3
vs History
vs Industry
Median 3Y
-6
Median 5Y
-6.2
Industry
6.5
vs History
88
vs Industry
35
Median 3Y
7.2
Median 5Y
8
Industry
5.7

Multiples Across Competitors

RCKT Competitors Multiples
Rocket Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
374.4m USD 0 -1.6 -0.7 -0.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
395.1B USD 6.6 168.3 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
174.1B USD 4.8 24.9 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
148.5B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD 9.8 31.4 23 24
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.7B USD 5.5 17 16.1 18.3
AU
CSL Ltd
ASX:CSL
85.8B AUD 3.7 18.9 12.8 15.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.5B USD 16.1 1 204.2 158.2 191.8
NL
argenx SE
XBRU:ARGX
44.3B EUR 14.5 34 58.6 60.2
P/S Multiple
Revenue Growth P/S to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average P/S: 3 377 238.2
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 770 229.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
2 086.1
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.1
46%
0.3
NL
argenx SE
XBRU:ARGX
14.5
49%
0.3
P/E Multiple
Earnings Growth PEG
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average P/E: 189.6
Negative Multiple: -1.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.3
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
9%
1.9
AU
CSL Ltd
ASX:CSL
18.9
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 204.2
N/A N/A
NL
argenx SE
XBRU:ARGX
34
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average EV/EBITDA: 39.4
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158.2
N/A N/A
NL
argenx SE
XBRU:ARGX
58.6
839%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Average EV/EBIT: 45.5
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
15.9
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.8
N/A N/A
NL
argenx SE
XBRU:ARGX
60.2
N/A N/A